Figure 1.
VitD3 decreases pneumococcal Th17 responses. 1 × 106 PBMCs/mL were pre-treated with 100 nmol/L VitD3 for 24 h, prior to stimulation with 1 μg/mL WCA for 5 days. Th17 frequency (A) was measured by flow cytometry. Th17 populations were determined by positive staining for cell surface markers obtained from live single lymphocytes. These were considered CD4+CD45+CD161+CD194+CD196+. IL-17A (B), IL-22 (C), IL-10 (D), IL-17A-IL-10 ratio (E), IL-22-IL-10 ratio and (F), concentrations were measured by an ELISA in pg/mL. Open circles represent untreated PBMCs, whilst closed circles represent VitD3 treated PBMCs. Data shown represents median ± IQR; n = 12 per group for cytokine analyses and n = 8 per group for flow cytometry.